Primary Prevention of Sudden Cardiac Death in Silent Cardiac Sarcoidosis
Authors:
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 4 (1) , 43-48
Abstract
Background—: Cardiac involvement in sarcoidosis is often silent and may lead to sudden death. This study was designed to assess the value of programmed electric stimulation of the ventricle (PES) for risk stratification in patients with sarcoidosis and evidence of preclinical cardiac involvement on imaging studies. Methods and Results—: Patients with biopsy-proven systemic sarcoidosis but without cardiac symptoms who had evidence of cardiac sarcoidosis on positron emission tomography (PET) or cardiac MRI (CMR) were included. All patients underwent baseline evaluation, echocardiographic assessment of left ventricular function, and programmed electric stimulation of the ventricle. Patients were followed for survival and arrhythmic events. Seventy-six patients underwent PES of the ventricle. Eight (11%) were inducible for sustained ventricular arrhythmias and received an implantable defibrillator. None of the noninducible patients received a defibrillator. Left ventricular ejection fraction was lower in patients with inducible ventricular arrhythmia (36.4±4.2% versus 55.8±1.5%, P P <0.0001). Conclusions—: In patients with biopsy-proven sarcoidosis and evidence of cardiac involvement on PET or CMR alone, positive PES may help to identify patients at risk for ventricular arrhythmia. More importantly, patients in this cohort with a negative PES appear to have a benign course within the first several years following diagnosis. PES may help to guide the use of implantable cardioverter defibrillators in this population.Keywords
This publication has 13 references indexed in Scilit:
- Detection of Myocardial Damage in Patients With SarcoidosisCirculation, 2009
- Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II PatientsJACC, 2006
- Usefulness of Programmed Ventricular Stimulation in Predicting Future Arrhythmic Events in Patients With Cardiac SarcoidosisThe American Journal of Cardiology, 2005
- Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis†European Heart Journal, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Clinical Characteristics of Patients in a Case Control Study of SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia deviceJACC, 1991
- Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmiasThe American Journal of Cardiology, 1986
- Usefulness of programmed stimulation in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1986
- Sarcoidosis of the heartThe American Journal of Medicine, 1977